abstract |
The present invention relates to a compound of formula (I); in free or pharmaceutically acceptable salt form, where R 1, R 2, R 3, R 4, R 5, m, n, w, X, Y and Q have the meanings as indicated in the specification, are useful for treating CRTh2 receptor-mediated conditions. , especially inflammatory or obstructive airway diseases. |